FIRST-IN-HUMAN PHASE 1A STUDY OF NG-641, A TUMOUR-SELECTIVE VECTOR EXPRESSING A FAP-TAC BISPECIFIC ANTIBODY AND IMMUNE ENHANCER MODULE, IN PATIENTS WITH METASTATIC/ADVANCED EPITHELIAL TUMOURS (STAR) Meeting Abstract

Open Access International Collaboration

cited authors

  • Simon, George; Subbiah, Vivek; Rosen, Lee; Lenz, Heinz-Josef; Park, Haeseong; Patel, Minesh; Miles, David; Wallis, Stephanie; Evilevitch, Vladimir; Krige, David; Powell, Mark; Lillie, Tom

Publication Date

  • November 1, 2022

webpage

published in

category

start page

  • A794

end page

  • A794

volume

  • 10